TG Therapeutics, Inc. (TGTX)

TG Therapeutics Stock Forecast

Stock Price Forecast

The 6 analysts that cover TG Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $50.67, which forecasts a 78.73% increase in the stock price over the next year. The lowest target is $39 and the highest is $60.

Price Target: $50.67 (+78.73%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$39	$50.67	$55	$60
Change	+37.57%	+78.73%	+94.00%	+111.64%

Analyst Ratings

The average analyst rating for TG Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Sep '25	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26
Strong Buy	3	4	3	3	3	3
Buy	1	1	1	1	1	2
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	6	5	5	5	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Brian Cheng JP Morgan	JP Morgan	Buy Maintains $49 → $46	Buy	Maintains	$49 → $46	+62.26%	Feb 2, 2026
Corinne Johnson Goldman Sachs	Goldman Sachs	Hold Maintains $37 → $39	Hold	Maintains	$37 → $39	+37.57%	Jan 15, 2026
Eric Joseph JP Morgan	JP Morgan	Buy Maintains $46 → $49	Buy	Maintains	$46 → $49	+72.84%	Nov 3, 2025
Emily Bodnar HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Initiates $60	Strong Buy	Initiates	$60	+111.64%	Oct 6, 2025
Mayank Mamtani B. Riley Securities	B. Riley Securities	Strong Buy Maintains $53 → $55	Strong Buy	Maintains	$53 → $55	+94.00%	Sep 17, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

622.60M

Increased by 89.24%

from 329.00M

Revenue Next Year

917.23M

Increased by 47.32%

from 622.60M

EPS This Year

3.04

Increased by 1,923.48%

from 0.15

EPS Next Year

1.74

Decreased by -42.62%

from 3.04

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	152.00K	6.69M	2.79M	233.66M	329.00M	622.60M	917.23M
Revenue Growth	-	4,300.66%	-58.36%	8,290.02%	40.80%	89.24%	47.32%
EPS	-2.42	-2.63	-1.65	0.09	0.15	3.04	1.74
EPS Growth	-	-	-	-	68.04%	1,923.48%	-42.62%
Forward PE	-	-	-	-	-	9.34	16.28
No. Analysts	-	-	-	-	-	10	10

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	655.5M	983.1M
Avg	622.6M	917.2M
Low	588.6M	849.5M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	99.2%	57.9%
Avg	89.2%	47.3%
Low	78.9%	36.4%

EPS Forecast

EPS	2025	2026	2027	2028	2029	2030
High	3.24	2.42
Avg	3.04	1.74
Low	2.77	1.24

EPS Growth

EPS Growth	2025	2026	2027	2028	2029	2030
High	2,063.0%	-20.4%
Avg	1,923.5%	-42.6%
Low	1,748.9%	-59.0%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.